Computational exploration of the significance of COPS6 in cancer: Functional and clinical relevance across tumor types

doi:10.5306/wjco.v14.i11.479

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1774)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series.

Item

Count

PDF

WORD

HTML

1101

Figures (1-7)

134

Sum=1298

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

318

Sum=417

Nov 24, 2023 (publication date) through Aug 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Nov 24, 2023; 14(11): 479-503
Published online Nov 24, 2023. doi: 10.5306/wjco.v14.i11.479

Full Size Figure Download Figure

Figure 3 Survival analysis of COP9 signalosome subunit 6. A: Overall survival (OS) and disease-free survival analysis conducted with the GEPIA2 website using the log-rank test (P < 0.05); B: Forest plots illustrating disease-specific survival (DSS), OS, progression-free interval (PFI), and disease-free interval (DFI) analyzed with Cox analysis in R software. ACC: Adrenocortical carcinoma; GBM: Glioblastoma multiforme; KICH: Kidney chromophobe; KIRP: Kidney renal papillary cell carcinoma; LGG: Lower grade glioma; LIHC: Liver hepatocellular carcinoma; LUAD: Lung adenocarcinoma; MESO: Mesothelioma; STAD: Stomach adenocarcinoma.

Citation: Wang SL, Zhuo GZ, Wang LP, Jiang XH, Liu GH, Pan YB, Li YR. Computational exploration of the significance of COPS6 in cancer: Functional and clinical relevance across tumor types. World J Clin Oncol 2023; 14(11): 479-503
URL: https://www.wjgnet.com/2218-4333/full/v14/i11/479.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i11.479